Suppr超能文献

作为具有抗高血压活性的血管紧张素Ⅱ1型受体(AT1)拮抗剂的5-氧代-1,2,4-恶二唑衍生物的设计、合成及药理评价

Design, synthesis, and pharmacological evaluation of 5-oxo-1,2,4-oxadiazole derivatives as AT1 antagonists with antihypertension activities.

作者信息

Zhu Weibo, Bao Xiaolu, Ren He, Liao Pingyong, Zhu Wei, Yan Yijia, Wang Li, Chen Zhilong

机构信息

a Department of Pharmaceutical Science and Technology , College of Chemistry and Biology, Donghua University , Shanghai , China.

b Department of Pharmacology , Shanghai Xianhui Pharmaceutical Co., Ltd , Shanghai , China.

出版信息

Clin Exp Hypertens. 2016;38(5):435-42. doi: 10.3109/10641963.2016.1151527. Epub 2016 Jun 30.

Abstract

A series of new 5-oxo-1,2,4-oxadiazole derivatives with 1, 4-disubsituted or 1, 5-disubsituted indole group was designed, synthesized, and pharmacologically evaluated. These derivatives displayed high affinities to the AT1 receptor at the same order of magnitude to losartan. The methyl ester with 1, 4-disubsituted indole group, 1 (5.01 ± 1.67 nM) showed high antihypertension activity on spontaneously hypertensive rats (SHRs). Its maximal response lowered 30 mmHg of mean blood pressure (MBP) at 10 mg/kg after oral administration, which was better than irbesartan, and the antihypertensive effect lasted beyond 24 h. These results made 1 deserve further investigation.

摘要

设计、合成并对一系列带有1,4 - 二取代或1,5 - 二取代吲哚基团的新型5 - 氧代 - 1,2,4 - 恶二唑衍生物进行了药理学评价。这些衍生物对AT1受体表现出与氯沙坦相同数量级的高亲和力。带有1,4 - 二取代吲哚基团的甲酯1(5.01±1.67 nM)对自发性高血压大鼠(SHR)显示出高抗高血压活性。口服给药后,其在10 mg/kg时的最大反应使平均血压(MBP)降低30 mmHg,优于厄贝沙坦,且抗高血压作用持续超过24小时。这些结果使化合物1值得进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验